HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genetic bases and clinical manifestations of coenzyme Q10 (CoQ 10) deficiency.

Abstract
Coenzyme Q(10) is a remarkable lipid involved in many cellular processes such as energy production through the mitochondrial respiratory chain (RC), beta-oxidation of fatty acids, and pyrimidine biosynthesis, but it is also one of the main cellular antioxidants. Its biosynthesis is still incompletely characterized and requires at least 15 genes. Mutations in eight of them (PDSS1, PDSS2, COQ2, COQ4, COQ6, ADCK3, ADCK4, and COQ9) cause primary CoQ(10) deficiency, a heterogeneous group of disorders with variable age of onset (from birth to the seventh decade) and associated clinical phenotypes, ranging from a fatal multisystem disease to isolated steroid resistant nephrotic syndrome (SRNS) or isolated central nervous system disease. The pathogenesis is complex and related to the different functions of CoQ(10). It involves defective ATP production and oxidative stress, but also an impairment of pyrimidine biosynthesis and increased apoptosis. CoQ(10) deficiency can also be observed in patients with defects unrelated to CoQ(10) biosynthesis, such as RC defects, multiple acyl-CoA dehydrogenase deficiency, and ataxia and oculomotor apraxia.Patients with both primary and secondary deficiencies benefit from high-dose oral supplementation with CoQ(10). In primary forms treatment can stop the progression of both SRNS and encephalopathy, hence the critical importance of a prompt diagnosis. Treatment may be beneficial also for secondary forms, although with less striking results.In this review we will focus on CoQ(10) biosynthesis in humans, on the genetic defects and the specific clinical phenotypes associated with CoQ(10) deficiency, and on the diagnostic strategies for these conditions.
AuthorsMaria Andrea Desbats, Giada Lunardi, Mara Doimo, Eva Trevisson, Leonardo Salviati
JournalJournal of inherited metabolic disease (J Inherit Metab Dis) Vol. 38 Issue 1 Pg. 145-56 (Jan 2015) ISSN: 1573-2665 [Electronic] United States
PMID25091424 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Ubiquinone
  • Adenosine Triphosphate
  • ubiquinol
Topics
  • Adenosine Triphosphate (chemistry)
  • Animals
  • Ataxia (diagnosis, genetics, physiopathology)
  • Central Nervous System Diseases (metabolism)
  • Disease Models, Animal
  • Electron Transport
  • Humans
  • Mice
  • Mitochondria (metabolism)
  • Mitochondrial Diseases (diagnosis, genetics, physiopathology)
  • Muscle Weakness (diagnosis, genetics, physiopathology)
  • Nephrotic Syndrome (metabolism)
  • Oxidative Stress
  • Phenotype
  • Ubiquinone (analogs & derivatives, chemistry, deficiency, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: